Experience with Invasive Infections at a Rural Hospital in the United States of America.
[INTRODUCTION] spp.
- 표본수 (n) 10
APA
Henrichs J, Gona S, et al. (2026). Experience with Invasive Infections at a Rural Hospital in the United States of America.. Surgical infections, 27(1), 68-72. https://doi.org/10.1177/10962964251389150
MLA
Henrichs J, et al.. "Experience with Invasive Infections at a Rural Hospital in the United States of America.." Surgical infections, vol. 27, no. 1, 2026, pp. 68-72.
PMID
41104501
Abstract
[INTRODUCTION] spp. are important human pathogens causing enteric disease or invasive infections commonly involving skin and soft tissue, biliary system, blood stream, and lung following aspiration. Only limited data regarding spp. infections from the United States are available.
[PATIENTS AND METHODS] This is a retrospective analysis of all infections caused by spp. during a four-year period at a rural hospital in the Appalachian region. Data were retrieved from electronic medical records, including the microbiology database.
[RESULTS] Between 10/2018 and 12/2022, 26 isolates of spp. in 21 patients (14 m/7 f) with a median age of 56 (range 0.1-86) years were identified. Six isolates were from blood cultures (four associated with biliary infections); 14 patients had soft-tissue infections, and one had acute cholecystitis. There were 18 isolates, two specimens grew , and one . In 10 cases, spp. was the only isolated organism; 11 infections (52%) were polymicrobial. Isolated co-pathogens were gram-positive cocci (6), gram-negative rods (6), and anaerobes (2). Nine patients underwent interventions (n = 10), including wound debridement (3), endoscopic retrograde cholangiopancreatography (ERCP) (3), percutaneous cholecystostomy (2), and laparoscopic cholecystectomy (2). Preferred antibiotics were fluoroquinolones (5), 3/4 generation cephalosporins (5), trimethoprim/sulfamethoxazole (TMPS) (2), and doxycycline (2). All infections were successfully treated, and all patients are currently alive except one, who died from metastatic pancreatic cancer.
[CONCLUSION] spp. are rare clinical pathogens but are capable of causing severe infections. Most patients in this series had surgical infections. Surgeons need to be aware that the organism has a propensity for causing biliary infections.
[PATIENTS AND METHODS] This is a retrospective analysis of all infections caused by spp. during a four-year period at a rural hospital in the Appalachian region. Data were retrieved from electronic medical records, including the microbiology database.
[RESULTS] Between 10/2018 and 12/2022, 26 isolates of spp. in 21 patients (14 m/7 f) with a median age of 56 (range 0.1-86) years were identified. Six isolates were from blood cultures (four associated with biliary infections); 14 patients had soft-tissue infections, and one had acute cholecystitis. There were 18 isolates, two specimens grew , and one . In 10 cases, spp. was the only isolated organism; 11 infections (52%) were polymicrobial. Isolated co-pathogens were gram-positive cocci (6), gram-negative rods (6), and anaerobes (2). Nine patients underwent interventions (n = 10), including wound debridement (3), endoscopic retrograde cholangiopancreatography (ERCP) (3), percutaneous cholecystostomy (2), and laparoscopic cholecystectomy (2). Preferred antibiotics were fluoroquinolones (5), 3/4 generation cephalosporins (5), trimethoprim/sulfamethoxazole (TMPS) (2), and doxycycline (2). All infections were successfully treated, and all patients are currently alive except one, who died from metastatic pancreatic cancer.
[CONCLUSION] spp. are rare clinical pathogens but are capable of causing severe infections. Most patients in this series had surgical infections. Surgeons need to be aware that the organism has a propensity for causing biliary infections.
MeSH Terms
Humans; Male; Female; Middle Aged; Aged; Gram-Negative Bacterial Infections; Retrospective Studies; Adult; Aged, 80 and over; Hospitals, Rural; Aeromonas; Young Adult; Adolescent; Child; Child, Preschool; United States; Anti-Bacterial Agents; Infant; Soft Tissue Infections